Executive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc. · Ventas, Inc. (VTR)

Peter Bulgarelli

A named executive officer of Ventas in every fiscal year CompBrief holds from FY2021 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$4,180,627

FY2021: $5,111,458

Compensation figures as of the proxy filed April 1, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-09-24.

Peter Bulgarelli compensation by year

Ventas Summary Compensation Table · all 2 fiscal years held
In US dollars, as Ventas reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2025
Salary$515,783$620,800
Bonus—$0
Stock awards$3,625,324$2,512,111
Option awards—$0
Non-equity incentive$953,941$1,015,763
Pension and deferred compensation—$0
All other$16,410$31,953
Total$5,111,458$4,180,627

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ventas, Inc. DEF 14A filed April 1, 2026, accession 0000740260-26-000010, and prior-year filings. Open the filing on EDGAR.

$5.1M
$4.2M
FY21
FY25
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU91,100$7,320,760—
RSU35,444$2,742,657—

Per the Outstanding Equity Awards at Fiscal Year-End table in Ventas, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2025 proxy (filed April 1, 2026)
current to 2026-09-24 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-05-01Tax withholding—2,372$88.02122,050
2026-05-01Tax withholding—1,496$88.02120,554
2026-05-01Tax withholding—2,346$88.02124,422

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Ventas’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Debra CafaroChairman and Chief Executive Officer$17,501,073
Robert ProbstExecutive Vice President and Chief Financial Officer$6,462,221
J. Justin HutchensExecutive Vice President, Senior Housing and Chief Investment Officer$6,349,630
Carey RobertsExecutive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary$4,189,849
Peter Bulgarelli · this pageExecutive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc.$4,180,627

The full Ventas compensation record

free company brief

This page is one person within Ventas's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Ventas's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ventas's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy